Philips inks $50M ‘long-term strategic partnership’ with New Jersey hospital system

Royal Philips announced this week that it’s inked a $50 million, five-year partnership with Inspira Health to help the New Jersey hospital system find more stability and predictability in its imaging strategy.

With the agreement, the hospital network plans to standardized diagnostic technology across its dozen-plus facilities, including three hospitals. In an announcement, Philips noted that such “long-term strategic partners” are becoming more common among hospitals as they aim to better manage their technology costs while also gaining access to the latest advancements.

“By working closely with Philips, we have an opportunity to stay at the cutting edge of imaging and patient monitoring,” John DiAngelo, president and CEO of Inspira, said in a statement. “This partnership will bring countless benefits to our patients, physicians and clinical teams. It comes down to ensuring that each individual community within our broader community is taken care of.”

The agreement comes as the hospital system works to open a state-of-the-art new hospital this month alongside a new cancer center in January. Those involved noted that signing such an agreement will also help with data integration and access across its more than 150 healthcare access points. Philips, meanwhile, gets the benefit of working more closely with a provider to understand their challenges and imaging needs. 

Philips and Inspira first announced the agreement on Monday, Dec. 2, at the Radiological Society of North America’s annual meeting in Chicago. 

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup